Perfluoroctylbromide and hepatosplenic computed tomography: Preliminary clinical study

J. N. Bruneton; M. N. Falewee; C. Balu-Maestro; F. Normand; R. F. Mattrey

Perfluoroctylbromide and hepatosplenic computed tomography: Preliminary clinical study

J. N. Bruneton, M. N. Falewee, C. Balu-Maestro, F. Normand, R. F. Mattrey

Research output: Contribution to journal › Article › peer-review

Abstract

The preliminary results of perfluoroctylbromide (PFOB) emulsion when used an an intravenous contrast agent for hepatosplenic CT imaging in humans are reported. Ten patients were examined using dosages ranging from 1 to 2 g/kg. There was good clinical and biochemical tolerance. Diagnostic dose for liver enhancement seems to be at least 2 g/kg, whereas 1 g/kg was sufficient for splenic enhancement.

Original language	English (US)
Pages (from-to)	S306-S307
Journal	Investigative Radiology
Volume	23
Issue number	SUPPL. 1
State	Published - Jan 1 1988

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Cite this

@article{7973ce1a9e87423a80747c905b6de67d,

title = "Perfluoroctylbromide and hepatosplenic computed tomography: Preliminary clinical study",

abstract = "The preliminary results of perfluoroctylbromide (PFOB) emulsion when used an an intravenous contrast agent for hepatosplenic CT imaging in humans are reported. Ten patients were examined using dosages ranging from 1 to 2 g/kg. There was good clinical and biochemical tolerance. Diagnostic dose for liver enhancement seems to be at least 2 g/kg, whereas 1 g/kg was sufficient for splenic enhancement.",

author = "Bruneton, {J. N.} and Falewee, {M. N.} and C. Balu-Maestro and F. Normand and Mattrey, {R. F.}",

year = "1988",

month = jan,

day = "1",

language = "English (US)",

volume = "23",

pages = "S306--S307",

journal = "Investigative Radiology",

issn = "0020-9996",

publisher = "Lippincott Williams and Wilkins",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Perfluoroctylbromide and hepatosplenic computed tomography

T2 - Preliminary clinical study

AU - Bruneton, J. N.

AU - Falewee, M. N.

AU - Balu-Maestro, C.

AU - Normand, F.

AU - Mattrey, R. F.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - The preliminary results of perfluoroctylbromide (PFOB) emulsion when used an an intravenous contrast agent for hepatosplenic CT imaging in humans are reported. Ten patients were examined using dosages ranging from 1 to 2 g/kg. There was good clinical and biochemical tolerance. Diagnostic dose for liver enhancement seems to be at least 2 g/kg, whereas 1 g/kg was sufficient for splenic enhancement.

AB - The preliminary results of perfluoroctylbromide (PFOB) emulsion when used an an intravenous contrast agent for hepatosplenic CT imaging in humans are reported. Ten patients were examined using dosages ranging from 1 to 2 g/kg. There was good clinical and biochemical tolerance. Diagnostic dose for liver enhancement seems to be at least 2 g/kg, whereas 1 g/kg was sufficient for splenic enhancement.

UR - http://www.scopus.com/inward/record.url?scp=0023749949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023749949&partnerID=8YFLogxK

M3 - Article

C2 - 3198367

AN - SCOPUS:0023749949

SN - 0020-9996

VL - 23

SP - S306-S307

JO - Investigative Radiology

JF - Investigative Radiology

IS - SUPPL. 1

ER -

Perfluoroctylbromide and hepatosplenic computed tomography: Preliminary clinical study

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this